scispace - formally typeset
M

Maria Grazia Modena

Researcher at University of Modena and Reggio Emilia

Publications -  243
Citations -  7741

Maria Grazia Modena is an academic researcher from University of Modena and Reggio Emilia. The author has contributed to research in topics: Coronary artery disease & Myocardial infarction. The author has an hindex of 44, co-authored 233 publications receiving 7031 citations. Previous affiliations of Maria Grazia Modena include University of Rome Tor Vergata.

Papers
More filters
Journal ArticleDOI

Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women.

TL;DR: This study demonstrates that a significant improvement in endothelial function may be obtained after six months of antihypertensive therapy and clearly identifies patients who possibly have a more favorable prognosis.
Journal ArticleDOI

A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up

TL;DR: Culprit vessel-only angioplasty was associated with the highest rate of long-term MACE compared with multivessel treatment and patients scheduled for staged revascularisation experienced a similar rate of MACE to patients undergoing complete simultaneous treatment of non-IRA.
Journal ArticleDOI

Differential Effects of β-Blockers in Patients With Heart Failure A Prospective, Randomized, Double-Blind Comparison of the Long-Term Effects of Metoprolol Versus Carvedilol

TL;DR: In this paper, the authors compared metoprolol and carvedilol in patients with chronic heart failure and found that carvedilols had greater anti-adrenergic effects than metoplrolol, but this pharmacological difference results in hemodynamic and clinical differences between the two drugs.
Journal ArticleDOI

Prognostic Role of Flow-Mediated Dilation and Cardiac Risk Factors in Post-Menopausal Women

TL;DR: In post-menopausal women, the knowledge of FMD provided incremental prognostic information regarding the risk of developing cardiovascular events, and Evaluation of endothelial function, utilizing the noninvasive measurement of the brachial artery FMD, may serve as a screening tool to individualize high-risk patients.